Indeed, a possible vitamin D therapeutic approach for treating COVID-19 aims at affecting the downregulation of RAS and ACE2, also in addition to angiotensin type 1 receptor (AT1R), which also can increase the expression of ACE2. Here, AGTR1 is linked to COVID-19.